Details of the Drug

General Information of Drug (ID: DMJPN84)

• Drug Name: BW-1010

Indication

Disease Entry	ICD 11	Status	REF
Anthrax	1B97	Phase 1	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: D21OLD

References

• [1] ClinicalTrials.gov (NCT04148118) A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults (IN NE-rPA). U.S. National Institutes of Health.